AZTR compared with MLSS: revenue, margins and what each company keeps, and the suppliers and customers both name

AZTRAzitra, Inc.

Mkt capRevenueRevenue

MLSSMilestone Scientific Inc.

Mkt capRevenueRevenue

Compare

AZTRAzitra, Inc.

MLSSMilestone Scientific Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

AZTR, solidMLSS, dashed

Supply-chain overlap

Revenue flow

AZTR: latest quarter is a loss; flow not drawable. MLSS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AZTR 1

—Fred Hutchinson Cancer Centerunlistedsupplier

Shared 0

No shared counterparties.

Only MLSS 1

—United Systemsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

AZTRAzitra, Inc.

0.77▲+1.92%· post 0.77

Mkt cap$4.7MRevenue$7,500Q2 FY24Revenue—

MLSSMilestone Scientific Inc.

0.31▼−0.32%· post 0.30

ClosedOct 30 '26

Mkt cap$27.0MRevenue$3MQ2 FY26Revenue$9MFY25

Compare

ClosedOct 30 '26

AZTRAzitra, Inc.

MLSSMilestone Scientific Inc.

0.77▲+1.92%post 0.77

Price

0.31▼−0.32%post 0.30

$4.7M

Mkt cap

$27.0M

Q2 FY24$7,500

Revenue

$3MQ2 FY26

—

Revenue

$9MFY25

AZTR0.77▲+1.92%vsMLSS0.31▼−0.32%ClosedOct 30 '26